Study: Enzyme could prove effective in treating tumors and inflammatory diseases in lung

Findings from a research study led by scientists at Henry Ford suggest an enzyme could play an important role in the treatment of cancer and autoimmune diseases in the airway. Histone deacetylases (HDACs) are enzymes that help modulate gene expression by removing acetyl groups from histone or non-histone proteins. Inhibition of HDACs is emerging as a promising approach to treat various types of malignant diseases and inflammatory disorders.